This year’s annual meeting of the European Society of Cardiology, set in Barcelona, Spain, carried a special spotlight on the growing power of cardiac imaging. Handheld ultrasounds, CT and MRI scans ...
An artificial intelligence program developed by researchers at Stanford University was able to streamline ultrasound exams of the heart—to the point where trained cardiologists couldn’t tell whether ...
Hot Line clinical trials from the European Society of Cardiology (ESC) Congress 2022—including REVIVED-BCIS2, DELIVER, PANTHER, INVICTUS, and data on oral factor XIa inhibitors—were among our ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
THOUSAND OAKS, Calif., Aug. 29, 2022 /PRNewswire/ -- Amgen (AMGN) today presented new compelling data from the Phase 3 FOURIER open label extension (OLE) studies of Repatha ® (evolocumab) in adults ...
BARCELONA -- Patients with documented coronary artery disease (CAD) saw cardiovascular benefits with P2Y12-inhibitor monotherapy when compared with aspirin alone, according to the PANTHER ...
Prof Wolfram Doehner, from the Center for Stroke Research in Berlin, Germany, discusses key abstracts in heart failure presented at the European Society of Cardiology Congress 2022. He starts with a ...
Factor XIa inhibitors milvexian and asundexian, hailed as the next-generation class of anticoagulants, earned mixed reviews on phase II data presented during the European Society of Cardiology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback